Alzamend Neuro - 53 Year Dividend History | ALZN
Historical dividend payout and yield for Alzamend Neuro (ALZN) since 1971. The current TTM dividend payout for Alzamend Neuro (ALZN) as of November 19, 2024 is $0.00. The current dividend yield for Alzamend Neuro as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.005B |
$0.000B |
|
Alzamed Neuro is an early clinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Their mission is to rapidly develop and market safe and effective treatments. Their current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
